| Detected | Trial | Change |
|---|---|---|
| 2026-07-07 | NCT07465679 A Real-world Study of Clinical Treatment Guidelines for Patients With Heart Failure With… |
Trial completed |
| 2026-07-07 | NCT07465679 A Real-world Study of Clinical Treatment Guidelines for Patients With Heart Failure With… |
Enrollment increased: 500 -> 2508 participants |
| 2026-07-07 | NCT07635316 A Study of Treatment Patterns and Outcomes in Gastroenteropancreatic Neuroendocrine Tumor… |
Recruitment opened |
| 2026-07-07 | NCT05344469 A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing… |
Trial sites expanded: 129 -> 138 locations |
| 2026-07-07 | NCT05870579 [177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+… |
Enrollment increased: 22 -> 28 participants |
| 2026-07-03 | NCT05827081 Phase IIIb Study of Ribociclib + ET in Early Breast Cancer |
Trial sites expanded: 220 -> 223 locations |
| 2026-07-03 | NCT02386800 CINC424A2X01B Rollover Protocol |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-07-03 | NCT02386800 CINC424A2X01B Rollover Protocol |
Trial sites reduced: 101 -> 97 locations |
| 2026-07-03 | NCT07174063 A Phase I Study of JSB462 (Luxdegalutamide) in Japanese Patients With Metastatic Prostate… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-07-03 | NCT07174063 A Phase I Study of JSB462 (Luxdegalutamide) in Japanese Patients With Metastatic Prostate… |
Enrollment reduced: 15 -> 6 participants |
| 2026-07-03 | NCT07421167 A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice… |
date change Primary completion moved earlier: 2029-01-10 -> 2028-04-01 |
| 2026-07-03 | NCT07421167 A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice… |
date change Completion moved earlier: 2030-09-18 -> 2030-08-08 |
| 2026-07-03 | NCT05445843 Study of Efficacy and Safety of JDQ443 Single-agent as First-line Treatment for Patients… |
Primary endpoint(s) modified |
| 2026-07-02 | NCT07598422 A Study to Assess the Effectiveness and Safety of Canakinumab in Clinical Use in Patients… |
Recruitment opened |
| 2026-07-02 | NCT07598422 A Study to Assess the Effectiveness and Safety of Canakinumab in Clinical Use in Patients… |
Enrollment increased: 5 -> 10 participants |
| 2026-07-02 | NCT07543120 An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients. |
Trial sites expanded: 7 -> 13 locations |
| 2026-07-01 | NCT07598448 A Study of Complement 3 Glomerulopathy (C3G) Patients Treated With Iptacopan Through an… |
date change Primary completion pushed: 2026-09-30 -> 2026-12-15 |
| 2026-07-01 | NCT07598448 A Study of Complement 3 Glomerulopathy (C3G) Patients Treated With Iptacopan Through an… |
date change Completion pushed: 2026-09-30 -> 2026-12-15 |
| 2026-07-01 | NCT06335979 An Ascending Dose Study of PIT565 in Participants With Systemic Lupus Erythematosus (SLE). |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-07-01 | NCT04925479 Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic… |
date change Primary completion pushed: 2026-06-16 -> 2027-09-21 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-07-06 | NCT07683065 A Study to Estimate Secukinumab Retention Rate in Psoriasis Patients With MASLD | Not Yet Recruiting | |
| 2026-07-06 | NCT07684469 Comparative Assessment of Inclisiran on Top of Standard of Care Versus Standard of Care… | Phase 4 | Not Yet Recruiting |
| 2026-07-02 | NCT07681258 A Study of Asciminib Safety and Efficacy in Young Adults With Chronic Myeloid Leukemia in… | Not Yet Recruiting | |
| 2026-07-02 | NCT07681271 A Phase 2 Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib… | Phase 2 | Not Yet Recruiting |
| 2026-07-01 | NCT07679269 Roll-Over Study of Alpelisib (BYL719) for Continued Access and Long-Term Safety. | Phase 2 | Not Yet Recruiting |
| 2026-06-30 | NCT07677254 A Study of Real-World Characteristics, Treatment Patterns, and Clinical Outcomes in… | Not Yet Recruiting | |
| 2026-06-30 | NCT07677267 A Study of Real-World Characteristics, Treatment Patterns, and Outcomes Among mCRPC… | Not Yet Recruiting | |
| 2026-06-24 | NCT07665437 An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With… | Phase 3 | Not Yet Recruiting |
| 2026-06-22 | NCT07660055 Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors | Phase 1 | Recruiting |
| 2026-06-22 | NCT07660172 A Study of Ianalumab in Addition to Eltrombopag in Pediatric Patients With Primary ITP… | Phase 2 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06501443 | LATAM LOWERS LDL-C | Hypercholesterolaemia | Recruiting |
| NCT07034690 | Study to Evaluate the Impact of a Targeted Lipid Optimization Program on LDL-C Control in… | Atherosclerotic Cardiovascular Disease | Recruiting |
| NCT06733922 | ELIOS - Investigational Biomarkers to Track Disease Modification in Active RRMS | Relapsing Remitting Multiple Sclerosis (RRMS) | Recruiting |
| NCT06372925 | Intravascular Imaging Study of the Effect of Inclisiran on Plaque in Patients With Acute… | Plaque, Atherosclerotic | Recruiting |
| NCT04638647 | Secukinumab Open Label Roll-over Extension Protocol | Autoimmunity, Inflammation | Recruiting |
| NCT07489573 | Study of Efficacy and Safety of Secukinumab in Chinese Adult Patients With Moderate to… | Hidradenitis Suppurativa (HS) | Recruiting |
| NCT05803941 | Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate… | Prostate Cancer | Recruiting |
| NCT04657822 | Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior… | Sickle Cell Disease | Recruiting |
| NCT06824103 | Study of Efficacy and Safety of Ruxolitinib in Chinese Participants With… | Graft vs. Host Disease | Recruiting |
| NCT03340506 | Dabrafenib and/or Trametinib Rollover Study | Melanoma | Recruiting |
| NCT04480853 | Safety and Efficacy Study of Fingolimod in Taiwanese Adults (≥ 20years) With Relapsing… | Multiple Sclerosis | Recruiting |
| NCT04877522 | Asciminib Roll-over Study | Chronic Myelogenous Leukemia | Recruiting |
| NCT05090371 | A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After… | Relapsing-Remitting Multiple Sclerosis | Active, Not Recruiting |
| NCT06941792 | Inclisiran Effectiveness in China: a Pragmatic Randomized Trial | Coronary Heart Disease | Active, Not Recruiting |
| NCT07448610 | ASsessing The REAl-world Safety & Effectiveness of Spinal Muscular Atrophy Participants… | Spinal Muscular Atrophy | Not Yet Recruiting |
| NCT05622708 | A Study of Secukinumab to Evaluate Maintenance of Response in Participants With… | Non-radiographic Axial Spondyloarthritis | Active, Not Recruiting |
| NCT02584933 | Roll-over Study to Allow Access to Certinib (LDK378) for Patients Who Are on Ceritinib… | ALK Positive Malignancies | Active, Not Recruiting |
| NCT05252585 | A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous… | Renal Angiomyolipoma | Active, Not Recruiting |
| NCT05161195 | Roll-over Study to Allow Continued Access to Ribociclib | Metastatic Breast Cancer | Active, Not Recruiting |
| NCT06444113 | Concentration of Ofatumumab in the Breast Milk of Lactating Women With Relapsing Forms of… | Multiple Sclerosis | Active, Not Recruiting |
| NCT02386800 | CINC424A2X01B Rollover Protocol | Primary Myelofibrosis | Active, Not Recruiting |
| NCT03975829 | Pediatric Long-Term Follow-up and Rollover Study | Diffuse Astrocytoma | Active, Not Recruiting |
| NCT07684469 | Comparative Assessment of Inclisiran on Top of Standard of Care Versus Standard of Care… | Acute Coronary Syndrome | Not Yet Recruiting |
| Phase 3 | |||
| NCT05335876 | Long-term Follow-up of Patients With Spinal Muscular Atrophy Treated With OAV101 in… | Spinal Muscular Atrophy (SMA) | Recruiting |
| NCT06597006 | Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With… | Familial Hypercholesterolemia - Homozygous | Recruiting |